Abnormal movements and diaphragmatic flutter in a case of suspected induced illness

  1. Rebecca Arvier 1,
  2. Thomas Clayton 2,
  3. Monique Dade 1 and
  4. Rahul S Joshi 3 , 4
  1. 1 General Paediatrics, Queensland Children's Hospital, South Brisbane, Queensland, Australia
  2. 2 Pharmacy Department, Queensland Children's Hospital, South Brisbane, Queensland, Australia
  3. 3 Paediatric Intensive Care Medicine, Queensland Children's Hospital, South Brisbane, Queensland, Australia
  4. 4 Children's Critical Care, Gold Coast University Hospital, Southport, Queensland, Australia
  1. Correspondence to Dr Rebecca Arvier; rebecca.arvier@health.qld.gov.au

Publication history

Accepted:29 Jan 2021
First published:07 Apr 2021
Online issue publication:07 Apr 2021

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

A 6-month-old girl presented to hospital via ambulance with a decreased conscious level (initial Glasgow Coma Scale of 3) and an abnormal breathing pattern described as diaphragmatic flutter. She then developed abnormal movements and continued to have episodes of fluctuating conscious levels so was transferred to a tertiary hospital paediatric intensive care unit for further investigation. During her 16-day stay in hospital, she continued to experience discrete episodes of drowsiness, bradycardia, unusual breathing patterns and abnormal movements which were associated with agitation, tachycardia, hypertension and insomnia. The patient underwent extensive investigation for her symptoms and, after some delay in waiting for initial results before considering a urine drug screen, she was ultimately found to have lisdexamfetamine and clonidine in her urine drug screen. Her symptoms subsequently resolved after her mother’s visits were restricted.

Background

Drug ingestion is an important differential to consider early in the presentation of abnormal movements and altered levels of consciousness in children. It is a differential which often does not present with a clear history, particularly in cases of non-accidental administration, and there is often a delay while awaiting results of extensive testing such as cerebrospinal fluid (CSF) results, PCRs and MRIs before a urine drug screen is considered and then a further delay while awaiting the results of urine drug analysis. These are important cases not to be missed, particularly in the case of non-accidental ingestion.

We report a case with an unusual constellation of symptoms given the two different classes of medications which were administered. A history of drug ingestion was not initially provided. Given repeat positive urine drug screens over 5 days, it was highly suspicious that the medication was continued to be inappropriately administered in hospital, highlighting the importance of strict control of formula preparation for infants in hospital.

Case presentation

A 6-month-old girl child initially presented to her general practitioner with an abnormal breathing pattern and a history of several days of coryzal symptoms. An ambulance was called for her altered level of consciousness and she was found to have a Glasgow Coma Scale of 3 when the ambulance arrived. She was urgently transferred to her closest peripheral hospital.

The infant was previously well with no significant medical history. There was no history of fevers, trauma or drug ingestion. She was immunised, took no regular medication and was achieving appropriate developmental milestones. She had no significant family history of seizures or other medical illness.

She was initially treated with intranasal midazolam by paramedics for potential seizures, then on arrival to the emergency department was empirically covered with ceftriaxone and aciclovir for possible meningitis. She had a CT brain performed which was normal and was observed on the ward for 48 hours.

The patient continued to have an abnormal pattern of breathing throughout her peripheral hospital admission, so her progress was discussed with subspecialty teams at the closest tertiary children’s hospital with a plan for an elective transfer to conduct further investigation. She then however progressed to having longer episodes of profound unresponsiveness warranting rapid response teams, resulting in an urgent retrieval to the paediatric intensive care unit at the tertiary children’s hospital.

Also complicating her diagnostically difficult case, she developed writhing, purposeless movements and increasing agitation with associated tachycardia and hypertension followed by intermittent bradycardia and periods of drowsiness. Doses of midazolam were trialled for abnormal movements with some improvement, but there were no changes in the breathing pattern.

While in the paediatric intensive care unit, her symptoms eventually settled, and she was discharged to the ward. Unfortunately, she developed a worsening of her movements, tachycardia and insomnia within 24 hours on the ward resulting in a re-admission to the paediatric intensive care unit. It was noted at this time she was flushed, agitated and had dilated reactive pupils.

The patient’s admission was also complicated by the loss of multiple peripheral cannulas and an extravasation injury from intravenous aciclovir.

Investigations

Throughout her admission, the major investigations performed included a lumbar puncture, with both bacterial cultures and viral PCRs which were all negative, a normal electroencephalogram (EEG) to investigate seizures and an MRI brain, spine and chest (to investigate potential phrenic nerve lesions causing diaphragmatic flutter) which was also negative. There were some normal baseline bloods including cell counts, electrolytes, thyroid function tests, blood glucose levels and liver function tests, and normal urine metabolic screens. An abdominal X-ray was performed (due to some abdominal distension) which showed non-specific extensive increased bowel gas.

As her diagnosis remained unclear, a urine drug screen was eventually performed and results became available on her second admission to the paediatric intensive care unit, which were positive for amfetamines. A more detailed analysis sent to another tertiary laboratory confirmed lisdexamfetamine and clonidine use. On further testing of multiple urines already provided to the pathology laboratory, lisdexamfetamine was present on initial presentation and then again 5 days later when she was re-admitted to the paediatric intensive care unit, suggesting a repeat ingestion on the ward. Clonidine was present in all four urine samples across 5 days. During the child’s admission, it was noted that her mother was preparing her feeds from a tin of open formula by her bedside.

Differential diagnosis

The patient was empirically covered for sepsis and meningitis given how profoundly unwell she was at presentation. Her CSF analysis and cultures were however negative, and her antibiotics were able to be ceased.

Seizures were also considered due to her decreased conscious levels and abnormal movements. Her movements did however appear to be more choreoathetoid in nature as opposed to rhythmic typical seizure-like movements. These episodes were not necessarily followed by postictal periods and there was no response to midazolam. She also had a normal EEG.

Another main differential was an intracerebral mass considering her altered levels of consciousness, abnormal movements and intermittent hypertension with associated bradycardia concerning for Cushing reflex. The possibility of a spinal cord or phrenic nerve lesion was also considered with her diaphragmatic flutter; however, a normal MRI brain, chest and spine excluded these differentials.

The final diagnosis of drug ingestion was considered after these main differentials were excluded.

Outcome and follow-up

The patient’s symptoms completely resolved. There was involvement with the child protection team, and she was eventually discharged into the care of a family friend with supervised visits allowed with her mother. Social work were also involved in her ongoing care.

Discussion

We found only one other case report of a 10-month infant admitted to hospital after an accidental lisdexamfetamine ingestion.1 The symptoms in that case included tachycardia, hypertension, dyskinesia and altered mental status. There were no abnormal breathing patterns and symptoms resolved within 12 hours of onset. The prolonged and fluctuating course in our case likely differed given the mix of lisdexamfetamine and clonidine, which was presumed to be administered in hospital (given the ongoing positive urine drugs screens).

Lisdexamfetamine is a centrally acting stimulant commonly used in the pharmacological management of attention deficit hyperactivity disorder (ADHD).2 The longer half life compared with other amfetamines allows single daily dosing.3 In our case, her mother initially reported none of the other family members living with the child were prescribed any ADHD medication.

Pharmacokinetically, lisdexamfetamine is unique, in that it does not rely on a controlled release formulation to exert its prolonged duration of action. Rather it is a prodrug, where dexamfetamine is conjugated with l-lysine.3 The conversion of this complex to the pharmacologically active dexamfetamine is via a rate-limited hydrolysis, primarily occurring in the blood stream.3 This results in a longer time-to-peak dexamfetamine concentration of 3.7 hours, compared with only 2 hours of immediate release dexamfetamine and a longer half-life of approximately 10 hours.3 4 As a prodrug, the rate-limited conversion to the active pharmaceutical moiety may well protect from severe toxicities. During clinical trials in rat models, the LD50 (lethal dose in 50% of rats) of lisdexamfetamine was five times the dose of dexamfetamine.4

Amfetamine toxidromes are characterised through the stimulation of the central and sympathetic nervous systems via increases in dopaminergic and noradrenergic signalling.4 Signs of toxicity can involve multiple body systems, with mild toxicities including tachycardia, hypertension, irritability, mydriasis and tremor.4 More severe toxidromes can cause seizures, hyperthermia, dysrhythmia, acidosis, rhabdomyolysis, ischaemic stroke, intracerebral haemorrhage and in rare cases coma/death.4

The other medication found in the patient’s urine, clonidine, is a drug first used clinically as an antihypertensive in the 1960s. Nowadays it has much broader clinical indications that see it used more commonly as an adjunct in pain management, sedation, as well as in ADHD. Clonidine is a central and peripherally acting alpha-adrenergic agonist, which has a high oral bioavailability and an elimination half-life of approximately 9 hours in those with normal renal function.4 Clonidine toxidromes unusually manifest in a range of cardiovascular and neurological symptoms commonly including hypotension, bradycardia, lethargy and large overdoses, which can result in respiratory depression, apnoea, ataxia and coma.4 Our case had evidence of these effects at various points in her admission. Management of clonidine toxidromes is primarily supportive, with a focus on maintenance of blood pressure and the airway.4

We did not find any association between abnormal breathing patterns and lisdexamfetamine or clonidine in the literature. Diaphragmatic flutter is a rare condition, particularly in the paediatric population.5 It has been described in conjunction with a wide range of conditions affecting the central nervous system, phrenic nerve and diaphragm.5 6 There have been a few published adult case studies of diaphragmatic flutter secondary to medications,6 such as galantamine, an acetylcholinesterase inhibitor used in Alzheimer’s treatment,7 and dopamine antagonists clebopride and domperidone.8 9 This is the first published case to our knowledge of a case of diaphragmatic flutter associated with either lisdexamfetamine or clonidine in an infant.

Learning points

  • Consider drug ingestion in a child with unexplained reduced conscious level.

  • Formula preparation and administration in hospital should be supervised and monitored to exclude induced illness.

  • Ingestion with different classes of drugs may not present as a classical toxidrome.

Acknowledgments

Ms Michele Cree, Pharmacist Lead - Critical Care, Queensland Children’s Hospital

Footnotes

  • Contributors The writing of this report was initially proposed by RSJ (PICU consultant). Planning was then conducted by RA (paediatric registrar) with RSJ and TC (pharmacist). The initial draft report was written by RA with the help of TC, who added specific information on the medications described in the report. There was then significant editing and suggestions on content from MD (general paediatric consultant) and RSJ .

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer